Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMed

Tracking in vitro biodegradation dynamics in cartilage tissue engineering using dual-labeled hydrogel/scaffold composites.

Kamaraj M., Caballero Aguilar L., Duchi S., Doyle SE., Rath SN., Moulton SE.

Laboratory Study, published in Biofabrication (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Biofabrication (2025)
Country
England
Reported sample size
—
Source database
PubMed
PMID
40706623
DOI
10.1088/1758-5090/adf3e7
Citations
2

Abstract (original English)

This study addresses the challenges of tracking cell-mediated biodegradation in cartilage tissue engineering, where hydrogels and scaffolds play a crucial role in providing structural support and promoting tissue regeneration. This research area has been rarely studied, offering potential insights into bridging the gap between in vitro and in vivo conditions for real-time monitoring of tissue regeneration alongside biodegradation. We developed dual-labeled hydrogel/scaffold composites for real-time monitoring of scaffold degradation in response to cell activity. Gelatin methacryloyl (GelMA) hydrogels are extensively explored for cartilage tissue engineering, albeit concerns remain regarding their mechanical properties under load-bearing conditions. To address this, a hydrogel/scaffold composite system was employed in this study, where a poly ( ϵ -caprolactone) (PCL) hex prism edge structure acts as a scaffold to support the cell-laden GelMA hydrogel. Fluorophore labeling of GelMA and PCL facilitated non-invasive monitoring of the hydrogel/scaffold composite biodegradation under cell proliferation conditions. Initially, the behavior of fluorescent-tagged Hydrogel/Scaffold was examined under accelerated degradation conditions. Subsequently, human adipose-derived mesenchymal stem cells loaded into fluorescent-labeled hydrogel/scaffolds were evaluated for their biocompatibility pot

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Tissue EngineeringTissue ScaffoldsHydrogelsHumansCartilageMesenchymal Stem CellsPolyestersGelatinChondrogenesisCell Proliferation

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.